Gyermekkori daganatok: vizsgálatok itt: Kína
611 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
- Where
- Chengdu, Guangzhou, Nanning
- Életkor
- 6 hónap to 30 év
- People
- 65 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT05533775 - No phaseTaking peopleStudy of Anxiety and Depression in Patients With Hematologic Malignancies
- Where
- Xiamen
- People
- 100
- Run by
- The First Affiliated Hospital of Xiamen University
See details and how to joinNCT07883070 - No phaseNot yet taking people in KínaBusulfan-Based Versus TBI-Based Conditioning for Adult ALL-CR2 Allo-HSCT
- Where
- Beijing
- Életkor
- 14 év to 65 év
- People
- 180
- Run by
- Peking University People's Hospital
See details and how to joinNCT07919470 - 1/2. fázisTaking peopleA Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
- Where
- Beijing, Changchun, Chengdu, Guangzhou, Hangzhou, Jinan, Nanchang, Nanjing, Tianjin, Wenzhou, Wuhan, Zhengzhou
- Életkor
- 2 év and over
- People
- 420 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT04811560 · EU 2023-506581-31-00 - No phaseNot yet taking people in KínaMulti-center Prospective Validation of Real-Time AI-EGGIM System
- Where
- Binzhou, Jinan, Qingdao
- People
- 540
- Run by
- Qilu Hospital of Shandong University
See details and how to joinNCT07915843 - No phaseTaking peopleRetroperitoneal Tumor Registry
- Where
- Changchun
- People
- 200
- Run by
- The First Hospital of Jilin University
See details and how to joinNCT07915895 - 1/2. fázisNot yet taking people in KínaMulti-CAR T Cell Therapy for Acute Myeloid Leukemia
- Where
- Shenzhen
- Életkor
- 2 év to 75 év
- People
- 10
- Run by
- Shenzhen Geno-Immune Medical Institute
See details and how to joinNCT03222674 - 1/2. fázisCsak meghívásosIntervention of Ovarian Cancer With Antigen-specific Engineered Immune Effectors
- Where
- Shenzhen
- Életkor
- 10 év to 80 év
- People
- 20
- Run by
- Shenzhen Geno-Immune Medical Institute
See details and how to joinNCT03393962 - 1/2. fázisNot yet taking people in KínaImmunotherapy Treating GI Cancer
- Where
- Shenzhen
- Életkor
- 1 év to 80 év
- People
- 100
- Run by
- Shenzhen Geno-Immune Medical Institute
See details and how to joinNCT03614650 - 1/2. fázisNot yet taking people in KínaCAR-T Immunotherapy Targeting CD19- ALL
- Where
- Shenzhen
- Életkor
- 6 hónap to 75 év
- People
- 100
- Run by
- Shenzhen Geno-Immune Medical Institute
See details and how to joinNCT04016129 - 1/2. fázisNot yet taking people in KínaMulti-CAR T Cell Therapy Targeting CD7-positive Malignancies
- Where
- Shenzhen
- Életkor
- 6 hónap to 75 év
- People
- 30
- Run by
- Shenzhen Geno-Immune Medical Institute
See details and how to joinNCT04033302 - 1/2. fázisNot yet taking people in KínaMulti-CAR-T Cells Targeting B Cell Lymphomas
- Where
- Shenzhen
- Életkor
- 6 hónap to 75 év
- People
- 11
- Run by
- Shenzhen Geno-Immune Medical Institute
See details and how to joinNCT04429438 - 1/2. fázisNot yet taking people in KínaTargeting CD276 (B7-H3) Positive Solid Tumors by 4SCAR-276
- Where
- Shenzhen
- Életkor
- 1 év to 75 év
- People
- 100
- Run by
- Shenzhen Geno-Immune Medical Institute
See details and how to joinNCT04432649 - 1/2. fázisNot yet taking people in KínaCombination Immunotherapy Targeting Sarcomas
- Where
- Shenzhen
- Életkor
- 1 év to 75 év
- People
- 20
- Run by
- Shenzhen Geno-Immune Medical Institute
See details and how to joinNCT04433221 - 1/2. fázisNot yet taking people in KínaCD19/22 Bi-specific CAR-T Cell Therapy
- Where
- Shenzhen
- Életkor
- 6 hónap to 75 év
- People
- 60
- Run by
- Shenzhen Geno-Immune Medical Institute
See details and how to joinNCT05432882 - 1/2. fázisNot yet taking people in KínaCD19/70 Bi-specific CAR-T Cell Therapy
- Where
- Shenzhen
- Életkor
- 6 hónap to 75 év
- People
- 30
- Run by
- Shenzhen Geno-Immune Medical Institute
See details and how to joinNCT05436496 - 1/2. fázisNot yet taking people in KínaGD2/PSMA Bi-specific CAR-T Cell Therapy
- Where
- Shenzhen
- Életkor
- 1 év to 75 év
- People
- 60
- Run by
- Shenzhen Geno-Immune Medical Institute
See details and how to joinNCT05437315 - 1/2. fázisNot yet taking people in KínaGD2/CD70 Bi-specific CAR-T Cell Therapy
- Where
- Shenzhen
- Életkor
- 1 év to 75 év
- People
- 30
- Run by
- Shenzhen Geno-Immune Medical Institute
See details and how to joinNCT05438368 - 1. fázisNot yet taking people in KínaUniversal 4SCAR7U Targeting CD7-positive Malignancies
- Where
- Shenzhen
- Életkor
- 6 hónap to 75 év
- People
- 30
- Run by
- Shenzhen Geno-Immune Medical Institute
See details and how to joinNCT05995028 - 1. fázisNot yet taking people in KínaUniversal CAR-T Cells Targeting AML
- Where
- Shenzhen
- Életkor
- 6 hónap to 75 év
- People
- 30
- Run by
- Shenzhen Geno-Immune Medical Institute
See details and how to joinNCT05995041 - 1/2. fázisNot yet taking people in KínaDLL3 CAR-T Therapy Targeting Brain Tumors
- Where
- Shenzhen
- Életkor
- 2 év to 70 év
- People
- 30
- Run by
- Shenzhen Geno-Immune Medical Institute
See details and how to joinNCT07180927 - 1/2. fázisNot yet taking people in KínaStudy on GD2 Positive Solid Tumors by 4SCAR-GD2
- Where
- Shenzhen
- Életkor
- 1 év to 65 év
- People
- 10
- Run by
- Shenzhen Geno-Immune Medical Institute
See details and how to joinNCT02992210 - 1/2. fázisNot yet taking people in KínaSafety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas
- Where
- Shenzhen
- Életkor
- 1 év to 75 év
- People
- 20
- Run by
- Shenzhen Geno-Immune Medical Institute
See details and how to joinNCT03356782 - 1. fázisNot yet taking people in KínaImmune Modulatory DC Vaccine Against Brain Tumor
- Where
- Shenzhen
- Életkor
- 1 év to 75 év
- People
- 10
- Run by
- Shenzhen Geno-Immune Medical Institute
See details and how to joinNCT03914768 - 1/2. fázisNot yet taking people in KínaPSMA-specific CAR-T Cell Therapy
- Where
- Shenzhen
- Életkor
- 1 év to 75 év
- People
- 100
- Run by
- Shenzhen Geno-Immune Medical Institute
See details and how to joinNCT04429451